Arunjyoti Bio Ventures Ltd
ABVLArunjyoti Bio Ventures Ltd
ABVL
Price Chart
Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 226.98 | 165.43 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.98 | 7.01 | 0.55% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Arunjyoti Bio Ventures is engaged in trading equities and commodities, software development operations, and bio ventures.
Peers
Compare with peersAdani Enterprises Ltd
MMTC Ltd
MSTC Ltd
Veritas (India) Ltd
Mercury Ev-Tech Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.21 | 39.27 | 0.05 | 3.72 | 7.31 | 5.51 | 3.25 | 1.74 | 20.47 | 27.86 | ||||||||||
Raw Materials | 0.21 | 0.00 | 0.00 | 3.14 | 6.09 | 4.67 | 2.87 | 2.38 | 10.30 | 21.48 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.02 | |||||||||||
| Employee Cost | 0.01 | 0.61 | 0.04 | 0.31 | 0.19 | 0.18 | 0.05 | 0.01 | 4.43 | |||||||||||
| Selling & Administrative Expenses | 0.05 | 1.10 | 0.20 | 0.23 | 0.90 | 0.18 | 0.12 | 0.07 | 1.39 | |||||||||||
| Operating & Other expenses | 0.00 | 37.32 | 0.04 | -0.01 | -0.00 | 0.39 | 0.13 | -0.89 | -1.49 | |||||||||||
EBITDA | -0.06 | 0.24 | -0.23 | 0.05 | 0.13 | 0.09 | 0.08 | 0.17 | 2.82 | 6.38 | ||||||||||
| Depreciation/Amortization | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.01 | 2.74 | ||||||||||
| PBIT | -0.07 | 0.24 | -0.23 | 0.05 | 0.13 | 0.09 | 0.08 | 0.17 | 0.81 | 3.64 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 2.11 | 2.75 | ||||||||||
| PBT | -0.07 | 0.24 | -0.24 | 0.05 | 0.13 | 0.08 | 0.08 | 0.16 | -1.30 | 0.89 | ||||||||||
| Taxes & Other Items | 0.00 | 0.04 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.04 | -0.95 | -0.40 | ||||||||||
| Net Income | -0.07 | 0.20 | -0.24 | 0.05 | 0.10 | 0.06 | 0.06 | 0.12 | -0.35 | 1.29 | ||||||||||
| EPS | -0.06 | 0.18 | -0.21 | 0.04 | 0.09 | 0.05 | 0.05 | 0.11 | -0.52 | 6.23 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
IndustrialsCommodities Trading
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Arunjyoti Bio Ventures Ltd | -836.58 | 165.43 | — |
| Adani Enterprises Ltd | 104.36 | 7.65 | 0.04% |
| MMTC Ltd | 61.25 | 7.24 | — |
| MSTC Ltd | 21.93 | 5.04 | 2.43% |
Price Comparison
Compare ABVL with any stock or ETFShareholdings
Promoter Holdings Trend
Increased Total Promoter Holding
In last 6 months, promoter holding in the company has increased by 12.82%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.08%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
ABVL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeArunjyoti Bio Ventures will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Arunjyoti Bio Ventures announced that the Annual General Meeting (AGM) of the company will be held on 14 September 2024.Powered by Capital Market - Live
Net profit of Arunjyoti Bio Ventures rose 4125.00% to Rs 1.69 crore in the quarter ended June 2024 as against Rs 0.04 crore during the previous quarter ended June 2023. Sales rose 260.71% to Rs 10.10 crore in the quarter ended June 2024 as against Rs 2.80 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales10.102.80 261 OPM %35.051.79 - PBDT2.970.05 5840 PBT2.250.05 4400 NP1.690.04 4125 Powered by Capital Market - Live
Arunjyoti Bio Ventures will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
Arunjyoti Bio Ventures reports standalone net profit of Rs 0.03 crore in the December 2022 quarter
Arunjyoti Bio Ventures standalone net profit declines 30.77% in the June 2021 quarter
Arunjyoti Bio Ventures reports standalone net loss of Rs 0.06 crore in the March 2021 quarter
Arunjyoti Bio Ventures reports standalone net loss of Rs 0.06 crore in the December 2020 quarter
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 40.64%, vs industry avg of 4.09%
Increasing Market Share
Over the last 5 years, market share increased from 0% to 0.01%